|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.41 USD | +1.91% |
|
-2.77% | +15.65% |
| 09/02 | Fastenal Company and RFK Racing announce Body Guard Brand as primary focus of partnership | RE |
| 05/02 | Baird Adjusts Fastenal Price Target to $51 From $49, Maintains Outperform Rating | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 18.41 | 20.54 | 21.2 | 20.6 | 21.22 | |||||
Return on Total Capital | 21.55 | 23.77 | 24.35 | 23.64 | 24.39 | |||||
Return On Equity % | 32.03 | 35.03 | 35.47 | 33.04 | 33.29 | |||||
Return on Common Equity | 32.03 | 35.03 | 35.47 | 33.04 | 33.29 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 46.2 | 46.07 | 45.66 | 45.08 | 45.01 | |||||
SG&A Margin | 25.95 | 25.24 | 24.85 | 25.07 | 24.82 | |||||
EBITDA Margin % | 23.09 | 23.35 | 23.22 | 22.34 | 22.38 | |||||
EBITA Margin % | 20.43 | 20.98 | 20.95 | 20.15 | 20.32 | |||||
EBIT Margin % | 20.25 | 20.82 | 20.81 | 20.01 | 20.19 | |||||
Income From Continuing Operations Margin % | 15.39 | 15.57 | 15.72 | 15.25 | 15.35 | |||||
Net Income Margin % | 15.39 | 15.57 | 15.72 | 15.25 | 15.35 | |||||
Net Avail. For Common Margin % | 15.39 | 15.57 | 15.72 | 15.25 | 15.35 | |||||
Normalized Net Income Margin | 12.56 | 12.89 | 12.95 | 12.49 | 12.61 | |||||
Levered Free Cash Flow Margin | 7.66 | 8.59 | 14.49 | 9.91 | 9.82 | |||||
Unlevered Free Cash Flow Margin | 7.76 | 8.72 | 14.58 | 9.97 | 9.87 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.45 | 1.58 | 1.63 | 1.65 | 1.68 | |||||
Fixed Assets Turnover | 4.74 | 5.55 | 5.8 | 5.77 | 5.91 | |||||
Receivables Turnover (Average Receivables) | 7.2 | 7.3 | 6.99 | 6.87 | 6.97 | |||||
Inventory Turnover (Average Inventory) | 2.26 | 2.33 | 2.47 | 2.62 | 2.66 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 4.19 | 3.96 | 4.57 | 4.67 | 4.85 | |||||
Quick Ratio | 1.67 | 1.57 | 1.98 | 1.99 | 2.13 | |||||
Operating Cash Flow to Current Liabilities | 1.13 | 1.19 | 2.17 | 1.71 | 1.81 | |||||
Days Sales Outstanding (Average Receivables) | 50.69 | 50.02 | 52.19 | 53.26 | 52.39 | |||||
Days Outstanding Inventory (Average Inventory) | 161.47 | 156.65 | 147.69 | 139.88 | 137.32 | |||||
Average Days Payable Outstanding | 23.49 | 22.56 | 24.88 | 23.67 | 23.92 | |||||
Cash Conversion Cycle (Average Days) | 188.68 | 184.12 | 174.99 | 169.47 | 165.79 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 20.93 | 25.36 | 15.98 | 13.42 | 11.21 | |||||
Total Debt / Total Capital | 17.31 | 20.23 | 13.78 | 11.83 | 10.08 | |||||
LT Debt/Equity | 15.98 | 16.07 | 11.31 | 8.62 | 7.88 | |||||
Long-Term Debt / Total Capital | 13.21 | 12.82 | 9.75 | 7.6 | 7.09 | |||||
Total Liabilities / Total Assets | 29.23 | 30.46 | 24.96 | 23.02 | 21.95 | |||||
EBIT / Interest Expense | 125.51 | 101.65 | 141.55 | 206.85 | 267.05 | |||||
EBITDA / Interest Expense | 157.98 | 124.44 | 172.17 | 254.32 | 325.85 | |||||
(EBITDA - Capex) / Interest Expense | 141.84 | 112.29 | 156.17 | 223.29 | 286.29 | |||||
Total Debt / EBITDA | 0.42 | 0.45 | 0.29 | 0.26 | 0.22 | |||||
Net Debt / EBITDA | 0.26 | 0.32 | 0.17 | 0.12 | 0.08 | |||||
Total Debt / (EBITDA - Capex) | 0.46 | 0.5 | 0.32 | 0.3 | 0.25 | |||||
Net Debt / (EBITDA - Capex) | 0.29 | 0.36 | 0.19 | 0.14 | 0.09 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 6.44 | 16.13 | 5.24 | 2.71 | 8.67 | |||||
Gross Profit, 1 Yr. Growth % | 8.15 | 15.79 | 4.31 | 1.41 | 8.5 | |||||
EBITDA, 1 Yr. Growth % | 6.43 | 17.44 | 4.65 | -1.21 | 8.87 | |||||
EBITA, 1 Yr. Growth % | 6.72 | 19.22 | 5.13 | -1.21 | 9.58 | |||||
EBIT, 1 Yr. Growth % | 6.62 | 19.4 | 5.17 | -1.22 | 9.65 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 7.67 | 17.5 | 6.27 | -0.38 | 9.37 | |||||
Net Income, 1 Yr. Growth % | 7.67 | 17.5 | 6.27 | -0.38 | 9.37 | |||||
Normalized Net Income, 1 Yr. Growth % | 6.63 | 19.22 | 5.69 | -0.91 | 9.74 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 7.38 | 18.12 | 6.88 | -0.99 | 9 | |||||
Accounts Receivable, 1 Yr. Growth % | 17 | 12.55 | 7.34 | 1.93 | 12.33 | |||||
Inventory, 1 Yr. Growth % | 13.91 | 12.1 | -10.85 | 8.03 | 6.26 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -0.96 | -0.67 | 2.26 | 4.25 | 7.85 | |||||
Total Assets, 1 Yr. Growth % | 8.43 | 5.81 | -1.88 | 5.27 | 7.55 | |||||
Tangible Book Value, 1 Yr. Growth % | 11.31 | 3.98 | 5.87 | 7.99 | 9.05 | |||||
Common Equity, 1 Yr. Growth % | 11.31 | 3.98 | 5.87 | 7.99 | 9.05 | |||||
Cash From Operations, 1 Yr. Growth % | -30.11 | 22.19 | 52.25 | -18.11 | 10.45 | |||||
Capital Expenditures, 1 Yr. Growth % | -6.84 | 10.98 | -0.58 | 31.08 | 8.3 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -40.28 | 30.34 | 77.44 | -29.76 | 7.68 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -39.96 | 30.56 | 75.95 | -29.77 | 7.54 | |||||
Dividend Per Share, 1 Yr. Growth % | 12 | 10.71 | 12.9 | 11.43 | 12.18 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 6.16 | 11.18 | 10.55 | 3.97 | 5.65 | |||||
Gross Profit, 2 Yr. CAGR % | 5.08 | 11.91 | 9.9 | 2.85 | 4.9 | |||||
EBITDA, 2 Yr. CAGR % | 7.29 | 11.8 | 10.86 | 1.68 | 3.71 | |||||
EBITA, 2 Yr. CAGR % | 7.58 | 12.8 | 11.95 | 1.91 | 4.04 | |||||
EBIT, 2 Yr. CAGR % | 7.31 | 12.83 | 12.06 | 1.92 | 4.07 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 8.15 | 12.48 | 11.74 | 2.89 | 4.38 | |||||
Net Income, 2 Yr. CAGR % | 8.15 | 12.48 | 11.74 | 2.89 | 4.38 | |||||
Normalized Net Income, 2 Yr. CAGR % | 7.57 | 12.75 | 12.26 | 2.34 | 4.28 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 7.68 | 12.63 | 12.36 | 2.87 | 3.88 | |||||
Accounts Receivable, 2 Yr. CAGR % | 10.16 | 14.76 | 9.92 | 4.6 | 7 | |||||
Inventory, 2 Yr. CAGR % | 5.6 | 13 | -0.03 | -1.86 | 7.14 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -0.19 | -0.82 | 0.78 | 3.25 | 6.03 | |||||
Total Assets, 2 Yr. CAGR % | 6.36 | 7.11 | 1.89 | 1.63 | 6.4 | |||||
Tangible Book Value, 2 Yr. CAGR % | 6.83 | 7.58 | 4.92 | 6.92 | 8.52 | |||||
Common Equity, 2 Yr. CAGR % | 6.83 | 7.58 | 4.92 | 6.92 | 8.52 | |||||
Cash From Operations, 2 Yr. CAGR % | -4.4 | -7.58 | 36.4 | 11.66 | -4.89 | |||||
Capital Expenditures, 2 Yr. CAGR % | -20.28 | 1.68 | 5.05 | 14.16 | 19.15 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 2.67 | -11.77 | 52.08 | 11.64 | -13.03 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 2.33 | -11.47 | 51.56 | 11.16 | -13.1 | |||||
Dividend Per Share, 2 Yr. CAGR % | 13.46 | 11.36 | 11.8 | 12.16 | 11.8 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 6.58 | 9.38 | 9.17 | 7.88 | 5.52 | |||||
Gross Profit, 3 Yr. CAGR % | 5 | 8.53 | 9.32 | 7 | 4.7 | |||||
EBITDA, 3 Yr. CAGR % | 6.88 | 10.57 | 9.36 | 6.68 | 4.02 | |||||
EBITA, 3 Yr. CAGR % | 6.99 | 11.33 | 10.18 | 7.38 | 4.4 | |||||
EBIT, 3 Yr. CAGR % | 6.82 | 11.2 | 10.22 | 7.44 | 4.43 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 7.15 | 11.18 | 10.37 | 7.55 | 5 | |||||
Net Income, 3 Yr. CAGR % | 7.15 | 11.18 | 10.37 | 7.55 | 5 | |||||
Normalized Net Income, 3 Yr. CAGR % | 6.98 | 11.33 | 10.35 | 7.68 | 4.75 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 6.89 | 11.06 | 10.68 | 7.72 | 4.87 | |||||
Accounts Receivable, 3 Yr. CAGR % | 8.02 | 10.95 | 12.23 | 7.19 | 7.12 | |||||
Inventory, 3 Yr. CAGR % | 6.02 | 7.72 | 4.42 | 2.59 | 0.77 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 10.9 | -0.35 | 0.2 | 1.93 | 4.76 | |||||
Total Assets, 3 Yr. CAGR % | 8.98 | 6.18 | 4.02 | 3 | 3.57 | |||||
Tangible Book Value, 3 Yr. CAGR % | 9.73 | 5.87 | 7.01 | 5.93 | 7.63 | |||||
Common Equity, 3 Yr. CAGR % | 9.73 | 5.87 | 7.01 | 5.93 | 7.63 | |||||
Cash From Operations, 3 Yr. CAGR % | 4.53 | 3.75 | 9.15 | 15.07 | 11.26 | |||||
Capital Expenditures, 3 Yr. CAGR % | -3.87 | -10.98 | 0.92 | 13.09 | 12.17 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 10.68 | 11.17 | 11.37 | 17.56 | 10.31 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 10.32 | 10.99 | 11.31 | 17.28 | 9.94 | |||||
Dividend Per Share, 3 Yr. CAGR % | 13.3 | 12.54 | 11.87 | 11.68 | 12.17 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 8.69 | 9.72 | 8.15 | 7.19 | 7.75 | |||||
Gross Profit, 5 Yr. CAGR % | 7.17 | 8.25 | 6.94 | 6.22 | 7.53 | |||||
EBITDA, 5 Yr. CAGR % | 9.07 | 10.09 | 8.46 | 6.92 | 7.07 | |||||
EBITA, 5 Yr. CAGR % | 9.07 | 10.61 | 8.95 | 7.46 | 7.68 | |||||
EBIT, 5 Yr. CAGR % | 8.89 | 10.54 | 8.89 | 7.39 | 7.72 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 13.12 | 13.44 | 8.96 | 7.79 | 7.93 | |||||
Net Income, 5 Yr. CAGR % | 13.12 | 13.44 | 8.96 | 7.79 | 7.93 | |||||
Normalized Net Income, 5 Yr. CAGR % | 8.88 | 10.55 | 9.06 | 7.64 | 7.88 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 13.11 | 13.58 | 9.05 | 7.71 | 7.91 | |||||
Accounts Receivable, 5 Yr. CAGR % | 12.49 | 10.76 | 8.77 | 8.37 | 10.11 | |||||
Inventory, 5 Yr. CAGR % | 8.94 | 9.34 | 3.55 | 3.78 | 5.5 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 6.99 | 6.99 | 6.74 | 1.07 | 2.49 | |||||
Total Assets, 5 Yr. CAGR % | 10 | 9.34 | 6.09 | 4.33 | 4.97 | |||||
Tangible Book Value, 5 Yr. CAGR % | 9.49 | 8.57 | 7.78 | 6.29 | 7.61 | |||||
Common Equity, 5 Yr. CAGR % | 9.49 | 8.57 | 7.78 | 6.29 | 7.61 | |||||
Cash From Operations, 5 Yr. CAGR % | 8.17 | 9.97 | 16.27 | 6.84 | 3.3 | |||||
Capital Expenditures, 5 Yr. CAGR % | -3.74 | 7.71 | -0.4 | -1.67 | 7.85 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 9.43 | 6.91 | 25.68 | 11.36 | 0.88 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 9.42 | 6.94 | 25.26 | 11.06 | 0.82 | |||||
Dividend Per Share, 5 Yr. CAGR % | 13.3 | 14.14 | 12.7 | 12.39 | 11.84 |
- Stock Market
- Equities
- FAST Stock
- Financials Fastenal Company
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















